SH-201

N/A

Report date: 2024/04/09 11:28:07
NME

Base Information

Drug NameSH-201
Drug Alias NameSH-201PIP-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyelodysplastic SyndromesGastrointestinal NeoplasmsLeukemia, Myelogenous, Chronic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesShorla Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShorla Oncology Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Myelogenous, ChronicPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia
Inactive IndicationsMyelodysplastic SyndromesGastrointestinal NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A